These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 33918105)

  • 41. Sudden death of a horse with supraventricular tachycardia following oral administration of flecainide acetate.
    Dembek KA; Hurcombe SD; Schober KE; Toribio RE
    J Vet Emerg Crit Care (San Antonio); 2014; 24(6):759-63. PubMed ID: 25388866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Flecainide-Associated Cardiogenic Shock in a Patient with Atrial Fibrillation.
    Gjermeni E; Bollmann A; Hindricks G; Müssigbrodt A
    Case Rep Cardiol; 2019; 2019():4820652. PubMed ID: 31827935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
    Jaeggi ET; Carvalho JS; De Groot E; Api O; Clur SA; Rammeloo L; McCrindle BW; Ryan G; Manlhiot C; Blom NA
    Circulation; 2011 Oct; 124(16):1747-54. PubMed ID: 21931080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of Flecainide for the Treatment of Atrial Fibrillation.
    Echt DS; Ruskin JN
    Am J Cardiol; 2020 Apr; 125(7):1123-1133. PubMed ID: 32044037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiarrhythmic and electrophysiologic effects of flecainide on acutely induced atrial fibrillation in healthy horses.
    Haugaard MM; Pehrson S; Carstensen H; Flethøj M; Hesselkilde EZ; Praestegaard KF; Diness JG; Grunnet M; Jespersen T; Buhl R
    J Vet Intern Med; 2015 Jan; 29(1):339-47. PubMed ID: 25328012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation.
    Capucci A; Piangerelli L; Ricciotti J; Gabrielli D; Guerra F
    Europace; 2016 Nov; 18(11):1698-1704. PubMed ID: 26893497
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion?
    Sarubbi B; Ducceschi V; D'Andrea A; Liccardo B; Santangelo L; Iacono A
    Can J Cardiol; 1998 Oct; 14(10):1267-73. PubMed ID: 9852940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias.
    Pritchett EL; Wilkinson WE
    Am J Cardiol; 1991 May; 67(11):976-80. PubMed ID: 1902055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of refractory supraventricular arrhythmias with flecainide acetate.
    Till JA; Rowland E; Shinebourne EA; Ward DE
    Arch Dis Child; 1987 Mar; 62(3):247-52. PubMed ID: 3105471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Flecainide for cardioversion in patients at elevated cardiovascular risk and persistent atrial fibrillation: a prospective observational study.
    Er F; Aslan O; Caglayan E; Gassanov N; Nia AM; Erdmann E; Rosenkranz S
    Clin Res Cardiol; 2010 Jun; 99(6):369-73. PubMed ID: 20180126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Epidemiology and therapy of atrial fibrillation].
    Capucci A; Aschieri D; Villani GQ
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():5S-10S. PubMed ID: 9004821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.
    Anderson JL; Gilbert EM; Alpert BL; Henthorn RW; Waldo AL; Bhandari AK; Hawkinson RW; Pritchett EL
    Circulation; 1989 Dec; 80(6):1557-70. PubMed ID: 2513143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
    Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
    Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm.
    Crozier IG; Ikram H; Kenealy M; Levy L
    Am J Cardiol; 1987 Mar; 59(6):607-9. PubMed ID: 3103410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
    Suttorp MJ; Kingma JH; Jessurun ER; Lie-A-Huen L; van Hemel NM; Lie KI
    J Am Coll Cardiol; 1990 Dec; 16(7):1722-7. PubMed ID: 2123909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter.
    Van Gelder IC; Crijns HJ; Van Gilst WH; Van Wijk LM; Hamer HP; Lie KI
    Am J Cardiol; 1989 Dec; 64(19):1317-21. PubMed ID: 2511744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation.
    Alp NJ; Bell JA; Shahi M
    Heart; 2000 Jul; 84(1):37-40. PubMed ID: 10862585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
    Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
    J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial.
    Kirchhof P; Andresen D; Bosch R; Borggrefe M; Meinertz T; Parade U; Ravens U; Samol A; Steinbeck G; Treszl A; Wegscheider K; Breithardt G
    Lancet; 2012 Jul; 380(9838):238-46. PubMed ID: 22713626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.